CISPLATIN
Substance profile for UNII Q20Q21Q62J, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.
Structure render from NCI/CADD chemical resolverSubstance Identity#
- UNII
- Q20Q21Q62J
- Preferred term
- CISPLATIN
- Registry number
- 15663-27-1
- EC number
- 239-733-8
- Ingredient type
- INGREDIENT SUBSTANCE
- Molecular formula
- 2Cl.Pt.2H3N
Chemical And Database Identifiers#
- SMILES
- N.N.[Cl-].[Cl-].[Pt++]
- RxCUI
- 2555
- PubChem
- 0
- NCIt
- C376
- INN ID
- 4426
DailyMed Socrata Ingredients#
Type, DailyMed label, SPL version table| Type | DailyMed label | SPL version |
|---|
| ACTIVE MOIETY | PLATINOL ® (cisplatin for injection, USP) | 4 |
| ACTIVE INGREDIENT | PLATINOL ® (cisplatin for injection, USP) | 4 |
| ACTIVE INGREDIENT | PLATINOL ® -AQ (cisplatin injection) | 3 |
| ACTIVE MOIETY | PLATINOL ® -AQ (cisplatin injection) | 3 |
| ACTIVE INGREDIENT | CISPLATIN INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] | 7 |
| ACTIVE MOIETY | CISPLATIN INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] | 7 |
| ACTIVE INGREDIENT | CISPLATIN INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 3 |
| ACTIVE MOIETY | CISPLATIN INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 3 |
| ACTIVE INGREDIENT | CISPLATIN INJECTION, SOLUTION [WG CRITICAL CARE, LLC] | 3 |
| ACTIVE MOIETY | CISPLATIN INJECTION, SOLUTION [WG CRITICAL CARE, LLC] | 3 |
| ACTIVE INGREDIENT | CISPLATIN INJECTION [MYLAN INSTITUTIONAL LLC ] | 1 |
| ACTIVE MOIETY | CISPLATIN INJECTION [MYLAN INSTITUTIONAL LLC ] | 1 |
| ACTIVE INGREDIENT | CISPLATIN INJECTION [PFIZER LABORATORIES DIV PFIZER INC.] | 1 |
| ACTIVE MOIETY | CISPLATIN INJECTION [PFIZER LABORATORIES DIV PFIZER INC.] | 1 |
mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=2555
ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C376
precision.fda.gov/uniisearch/srs/unii/Q20Q21Q62J
commonchemistry.cas.org/results?q=239-733-8